The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial

de, Z., Koster, J., Manolis, A., Navis, G., Reid, J. and Vogt, L. (2005) The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. Journal of Hypertension, 23, pp. 2055-2061.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Reid, Professor John
Authors: de, Z., Koster, J., Manolis, A., Navis, G., Reid, J., and Vogt, L.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Journal of Hypertension

University Staff: Request a correction | Enlighten Editors: Update this record